Conventionally, the primary PD-1 ligand expressed on the surface of tumor cells or antigen-presenting cells is PD-L1, with PD-1 on T cells to trigger inhibitory signaling (Curiel et al., 2003, 2007; Keir et al., 2008; Lin et al., 2018). Here, CD274 is linked to neoplasm.